Reset Map12 Results
Asymchem Life Science (Tianjin) Co., Ltd. No. 71, 7th Avenue TEDA, Tianjin, 300457 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
No.265, South Avenue, TEDA WEST, Binhai New Area, Tianjin, 300462, P. R. China TEDA WEST, Binhai New Area, Tianjin, Tianjin, 300462 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
600 Airport Blvd Suite 1000 Morrisville, NC - North Carolina, 27560 United StatesAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
No.6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R.China Tianjin, 300457 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
No.6, Xinzhang Road, TEDA WEST, Binhai New Area, Tianjin, 300462, P.R China Tianjin, 300462 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
Center of Flow&Continuous Technology, No.265, South Avenue, TEDA WEST, Binhai New Area, Tianjin, 300462, P.R.China Tianjin, 300462 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
905 Turnpike St Canton, MA, 02021 United StatesAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
DISCOVERY PARK HOUSE, BUILDING 530, RAMSGATE ROAD, SANDWICH, ENGLAND, CT13 9ND Sandwich, Sandwich, CT13 9ND United KingdomAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
Building 8, No. 15, Lane 855, Jinzheng Road, and Building 1, No. 518 Haoye Road, 4th floor, Jinshan Industrial Zone, Shanghai, 201517, P.R. China Shanghai, China, Shanghai, 201517 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
1st Floor, Building 2, No.1876 Chenqiao Road, Fengxian District, Shanghai, 201400, P.R. China Shanghai, China, Shanghai, 201400 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
Room 206, No. 6, Lane 999, Raike Road, Shanghai Pilot Free Trade Zone, 201208, P.R. China Shanghai, China, Shanghai, 201208 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
10 Gill Street Suite J Woburn, MA, 01801 United StatesAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.